Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Annick DesJardins
Duke University, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Istari Oncology
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Desjardins has IP being used in clinical trials which will be supported by grant carryover funds with NCI approval. The IP has been licensed to Istari, a company in which she has equity.
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
RELEVANCE: Two of the conditions in neuro-oncology that are most refractory to treatment are neoplastic meningitis (NM) and glioblastoma multiforme (GBM). NM from carcinoma of the breast and lung are the most common subtypes, with a median survival of 2-6 months. GBM is the most common and most malignant primary brain tumor, with median survival at recurrence being 15-18 months. This application proposes novel targeted approaches for treatment of these two very refractory conditions.
Filed on July 27, 2017.
Tell us what you know about Annick DesJardins's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Annick DesJardins”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Annick DesJardins | Duke University | Conflict of Interest | None | Value cannot be readily determined |
| Annick DesJardins | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| Annick DesJardins | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| Annick DesJardins | Duke University | Conflict of Interest | Istari Oncology | Value cannot be readily determined |
| Annick DesJardins | Duke University | Conflict of Interest | None - unlicensed IP | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.